{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:33:33Z","timestamp":1791556413373,"version":"4.3.4"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.micpath.2026.108667","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:35:24Z","timestamp":1782747324000},"page":"108667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["New perspectives in the research of Helicobacter pylori vaccine"],"prefix":"10.1016","volume":"218","author":[{"given":"Qingsong","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2026.108667_bib1","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2024.2425773","article-title":"Adjuvants for Helicobacter pylori vaccines: outer membrane vesicles provide an alternative strategy","volume":"15","author":"Zhang","year":"2024","journal-title":"Virulence"},{"issue":"3","key":"10.1016\/j.micpath.2026.108667_bib2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3390\/foods14030406","article-title":"Synergistic anti-helicobacter pylori effects of Takifugu obscurus skin peptides and Lactobacillus plantarum: a potential gastric Health Dietary supplement","volume":"14","author":"Gu","year":"2025","journal-title":"Foods"},{"key":"10.1016\/j.micpath.2026.108667_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1523991","article-title":"Pivotal role of Helicobacter pylori virulence genes in pathogenicity and vaccine development","volume":"11","author":"Elbehiry","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.micpath.2026.108667_bib4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s10120-023-01461-7","article-title":"Sustained exposure to Helicobacter pylori induces immune tolerance by desensitizing TLR6","volume":"27","author":"Zhang","year":"2024","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.micpath.2026.108667_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.938608","article-title":"Relationship between Helicobacter pylori infection and gastrointestinal microecology","volume":"12","author":"Xu","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108667_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114549","article-title":"Targeting Hippo pathway: a novel strategy for helicobacter pylori-induced gastric cancer treatment","volume":"161","author":"Liu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.micpath.2026.108667_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.12998\/wjcc.v4.i1.5","article-title":"Treatment of Helicobacter pylori infection: current and future insights","volume":"4","author":"Safavi","year":"2016","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.micpath.2026.108667_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","article-title":"Helicobacter pylori infection","volume":"9","author":"Malfertheiner","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.micpath.2026.108667_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijid.2020.05.077","article-title":"Population-based study of Helicobacter pylori infection and antibiotic resistance in Bhutan","volume":"97","author":"Vilaichone","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108667_bib10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41598-021-04151-5","article-title":"Fucoidan from sargassum hemiphyllum inhibits infection and inflammation of Helicobacter pylori","volume":"12","author":"Chen","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108667_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41541-024-00914-z","article-title":"A safe and potentiated multi-type HPV L2-E7 nanoparticle vaccine with combined prophylactic and therapeutic activity","volume":"9","author":"Zhao","year":"2024","journal-title":"npj Vaccines"},{"key":"10.1016\/j.micpath.2026.108667_bib12","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4103\/ijmr.IJMR_3514_20","article-title":"Role of alternatives to antibiotics in mitigating the antimicrobial resistance crisis","volume":"156","author":"Gupta","year":"2022","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.micpath.2026.108667_bib13","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1128\/IAI.70.11.6383-6388.2002","article-title":"Protection against experimental Helicobacter pylori infection after immunization with inactivated H. pylori whole-cell vaccines","volume":"70","author":"Raghavan","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108667_bib14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3390\/toxins15090563","article-title":"Recent developments in vaccine design: from live vaccines to recombinant toxin vaccines","volume":"15","author":"Gupta","year":"2023","journal-title":"Toxins"},{"key":"10.1016\/j.micpath.2026.108667_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biologicals.2016.10.002","article-title":"Protection of mice against gastric colonization of Helicobacter pylori by therapeutic immunization with systemic whole cell inactivated vaccines","volume":"45","author":"Suganya","year":"2017","journal-title":"Biologicals"},{"key":"10.1016\/j.micpath.2026.108667_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101183","article-title":"Vaccination against Helicobacter pylori \u2013 an approach for cancer prevention?","volume":"92","author":"Friedrich","year":"2023","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.micpath.2026.108667_bib17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1146\/annurev-pharmtox-030320-092348","article-title":"Oral biologic delivery: advances toward oral subunit, DNA, and mRNA vaccines and the potential for mass vaccination during pandemics","volume":"61","author":"Coffey","year":"2021","journal-title":"Annu. Rev. Pharmacol."},{"issue":"5","key":"10.1016\/j.micpath.2026.108667_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3892\/etm.2024.12511","article-title":"Recent development of oral vaccines","volume":"27","author":"Liu","year":"2024","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.micpath.2026.108667_bib19","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1128\/IAI.69.6.3581-3590.2001","article-title":"Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection","volume":"69","author":"Kotloff Karen","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2026.108667_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102304","article-title":"Genome and population dynamics during chronic infection with Helicobacter pylori","volume":"82","author":"Suerbaum","year":"2023","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.micpath.2026.108667_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.micres.2018.09.011","article-title":"Helicobacter pylori evasion strategies of the host innate and adaptive immune responses to survive and develop gastrointestinal diseases","volume":"218","author":"Karkhah","year":"2019","journal-title":"Microbiol. Res."},{"issue":"8","key":"10.1016\/j.micpath.2026.108667_bib22","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3390\/biom11081072","article-title":"Platforms for production of protein-based vaccines: from classical to next-generation strategies","volume":"11","author":"Cid","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.micpath.2026.108667_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.csbj.2025.10.008","article-title":"Advances in the structure-based design of protein vaccines for respiratory infectious diseases","volume":"29","author":"Tie","year":"2025","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.micpath.2026.108667_bib26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/intimm\/dxab044","article-title":"Helicobacter urease suppresses cytotoxic CD8+ T-cell responses through activating Myh9-dependent induction of PD-L1","volume":"33","author":"Wu","year":"2021","journal-title":"Int. Immunol."},{"key":"10.1016\/j.micpath.2026.108667_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1419568","article-title":"Implications of silver nanoparticles for H. pylori infection: modulation of CagA function and signaling","volume":"14","author":"Hochvaldova","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108667_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2025.128142","article-title":"VacA promotes pyroptosis via TNFAIP3\/TRAF1 signaling to induce onset of atrophic gastritis","volume":"296","author":"Xiao","year":"2025","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.micpath.2026.108667_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/srep46499","article-title":"Host determinants of expression of the Helicobacter pylori BabA adhesin","volume":"7","author":"Kable","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108667_bib30","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1126\/science.1069076","article-title":"Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation","volume":"297","author":"Mahdavi","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.micpath.2026.108667_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.944139","article-title":"HP-NAP of Helicobacter pylori: the Power of the Immunomodulation","volume":"13","author":"Codolo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108667_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02952-23","article-title":"Unraveling the crystal structure of the HpaA adhesin: insights into cell adhesion function and epitope localization of a Helicobacter pylori vaccine candidate","volume":"15","author":"Martini","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.micpath.2026.108667_bib33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1099\/jmm.0.46891-0","article-title":"A Helicobacter hepaticus catalase mutant is hypersensitive to oxidative stress and suffers increased DNA damage","volume":"56","author":"Hong","year":"2007","journal-title":"J. Med. Microbiol."},{"issue":"12","key":"10.1016\/j.micpath.2026.108667_bib34","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/pathogens11121544","article-title":"Antigenic determinant of Helicobacter pylori FlaA for developing serological diagnostic methods in children","volume":"11","author":"Park","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.micpath.2026.108667_bib35","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1099\/mic.0.27527-0","article-title":"Helicobacter pylori heat-shock protein 60 induces inflammatory responses through the Toll-like receptor-triggered pathway in cultured human gastric epithelial cells","volume":"150","author":"Takenaka","year":"2004","journal-title":"Microbiology (Read.)"},{"key":"10.1016\/j.micpath.2026.108667_bib36","doi-asserted-by":"crossref","first-page":"8587","DOI":"10.1038\/s41598-024-59234-w","article-title":"Probing the expression and adhesion of glycans involved in Helicobacter pylori infection","volume":"14","author":"Sijmons","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2026.108667_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/571280","article-title":"Helicobacter pylori outer membrane protein 18 (Hp1125) is involved in persistent colonization by evading Interferon-\u03b3 signaling","volume":"2015","author":"Shan","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.micpath.2026.108667_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0317227","article-title":"Development and optimization of a new competitive ELISA using recombinant (rPSA D15 and rCag11) antigens for the detection of Helicobacter pylori infection","volume":"20","author":"Eskeziyaw","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2026.108667_bib24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/1040841X.2023.2215303","article-title":"Subunit vaccines: recent progress and challenges","volume":"50","author":"Lau","year":"2024","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2026.108667_bib25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fimmu.2020.00283","article-title":"Designs of antigen structure and composition for improved protein-based vaccine efficacy","volume":"11","author":"Saylor","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108667_bib39","first-page":"fuaf034","article-title":"Advances in Helicobacter pylori lipopolysaccharide structure and function","volume":"49","author":"Tang","year":"2025","journal-title":"FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Rev."},{"key":"10.1016\/j.micpath.2026.108667_bib40","doi-asserted-by":"crossref","first-page":"14535","DOI":"10.1021\/jacs.2c03068","article-title":"Chemical synthesis of the highly sterically hindered core undecasaccharide of Helicobacter pylori lipopolysaccharide for antigenicity evaluation with human serum","volume":"144","author":"Zou","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.micpath.2026.108667_bib41","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1016\/j.vaccine.2011.02.063","article-title":"Synthesis and immunogenicity of a Helicobacter pylori lipopolysaccharide-based conjugate","volume":"29","author":"Monteiro","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108667_bib42","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1016\/j.vaccine.2020.02.036","article-title":"Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection","volume":"38","author":"Liu","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108667_bib43","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0140-6736(15)60310-5","article-title":"Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"386","author":"Zeng","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2026.108667_bib44","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0016-5085(99)70063-6","article-title":"Oral immunization with urease and heat-labile enterotoxin is safe and immunogenicin-infected adults","volume":"116","author":"Michetti","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.micpath.2026.108667_bib45","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1038\/s41467-025-59826-8","article-title":"Mpox multiprotein virus-like nanoparticle vaccine induces neutralizing and protective antibodies in mice and non-human primates","volume":"16","author":"Belghith","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108667_bib46","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3390\/vaccines12101112","article-title":"Ferritin vaccine platform for animal and zoonotic viruses","volume":"12","author":"Ahmadivand","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.micpath.2026.108667_bib47","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1021\/acs.molpharmaceut.3c00536","article-title":"Liposome vaccine for active regulation of cellular and humoral immunity","volume":"20","author":"Luo","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.micpath.2026.108667_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2024.105433","article-title":"Intranasal immunization with poly I:C and CpG ODN adjuvants enhances the protective efficacy against Helicobacter pylori infection in mice","volume":"27","author":"Sun","year":"2025","journal-title":"Microb. Infect."},{"key":"10.1016\/j.micpath.2026.108667_bib49","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1126\/science.8456302","article-title":"Heterologous protection against influenza by injection of DNA encoding a viral protein","volume":"259","author":"Ulmer","year":"1993","journal-title":"Science (Wash. D C)"},{"key":"10.1016\/j.micpath.2026.108667_bib50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00430-002-0144-z","article-title":"DNA immunization--a new chance in vaccine research?","volume":"191","author":"Henke","year":"2002","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.micpath.2026.108667_bib51","doi-asserted-by":"crossref","first-page":"13225","DOI":"10.1002\/anie.202010282","article-title":"Biopolymer-based carriers for DNA vaccine design","volume":"60","author":"Franck","year":"2021","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"11","key":"10.1016\/j.micpath.2026.108667_bib52","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.3390\/ijms19113605","article-title":"DNA vaccines-how far from clinical use?","volume":"19","author":"Hobernik","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108667_bib53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.11599\/germs.2013.1034","article-title":"DNA vaccines: roles against diseases","volume":"3","author":"Khan","year":"2013","journal-title":"Germs"},{"key":"10.1016\/j.micpath.2026.108667_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39433","article-title":"A new multi-epitope DNA vaccine against Helicobacter Pylori infection in a BALB\/c mouse model","volume":"10","author":"Azami","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.micpath.2026.108667_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127692","article-title":"Chitosan-based Oral DNA vaccine elicits mucosal immunity and reduces colonization in mice","volume":"64","author":"Chan","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108667_bib56","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3748\/wjg.v13.i6.939","article-title":"Construction of recombinant attenuated Salmonella typhimurium DNA vaccine expressing H pylori ureB and IL-2","volume":"13","author":"Xu","year":"2007","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.micpath.2026.108667_bib57","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/ijms25021076","article-title":"Solid lipid nanoparticles delivering a DNA vaccine encoding Helicobacter pylori urease A subunit: immune analyses before and after a mouse model of infection","volume":"25","author":"Francis","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108667_bib58","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3748\/wjg.v11.i1.114","article-title":"Construction of a recombinant attenuated Salmonella typhimurium DNA vaccine carrying Helicobacter pylori hpaA","volume":"11","author":"Xu","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.micpath.2026.108667_bib59","first-page":"796","article-title":"DNA vaccine containing Flagellin A gene induces significant immune responses against Helicobacter pylori infection: an in vivo study","volume":"24","author":"Ansari","year":"2021","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.micpath.2026.108667_bib60","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1080\/14760584.2021.1988854","article-title":"Use of lentiviral vectors in vaccination","volume":"20","author":"Ku","year":"2021","journal-title":"Expert Rev. Vaccine"},{"key":"10.1016\/j.micpath.2026.108667_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102210","article-title":"Viral vector vaccines","volume":"77","author":"McCann","year":"2022","journal-title":"Curr. Opin. Immunol."},{"issue":"3","key":"10.1016\/j.micpath.2026.108667_bib62","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3390\/pharmaceutics15030846","article-title":"Lentiviral vectors as a vaccine platform against infectious diseases","volume":"15","author":"Nemirov","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micpath.2026.108667_bib63","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1172\/JCI78280","article-title":"Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling","volume":"125","author":"Quinn","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.micpath.2026.108667_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113834","article-title":"Nucleic acid delivery for therapeutic applications","volume":"178","author":"Gupta","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.micpath.2026.108667_bib65","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/14760584.2023.2268724","article-title":"Mucosal vaccination: onward and upward","volume":"22","author":"Tsai","year":"2023","journal-title":"Expert Rev. Vaccine"},{"key":"10.1016\/j.micpath.2026.108667_bib66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/mi.2007.6","article-title":"The immune geography of IgA induction and function","volume":"1","author":"Macpherson","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.micpath.2026.108667_bib67","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41541-025-01302-x","article-title":"Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms","volume":"10","author":"Pineda-Pe\u00f1a","year":"2025","journal-title":"npj Vaccines"},{"key":"10.1016\/j.micpath.2026.108667_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122628","article-title":"mRNA vaccines contribute to innate and adaptive immunity to enhance immune response in vivo","volume":"310","author":"Cao","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.micpath.2026.108667_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18800","article-title":"Physicochemical properties and adsorption state of aluminum adjuvants with different processes in vaccines","volume":"9","author":"Bo","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.micpath.2026.108667_bib70","article-title":"All-Retinoic acid-adjuvanted mRNA vaccine induces mucosal anti-tumor immune responses for treating colorectal cancer","volume":"11","author":"Li","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.micpath.2026.108667_bib71","doi-asserted-by":"crossref","first-page":"39043","DOI":"10.1021\/acsnano.5c09796","article-title":"Neutrophil granule-mimetic emulsion inducing gastrointestinal immunity against Helicobacter pylori via subcutaneous vaccination","volume":"19","author":"Xie","year":"2025","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.micpath.2026.108667_bib72","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3390\/pharmaceutics15061772","article-title":"Use of poly lactic-co-glycolic acid Nano and Micro particles in the delivery of drugs modulating different phases of inflammation","volume":"15","author":"Puricelli","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micpath.2026.108667_bib73","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejpb.2016.11.007","article-title":"Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55\/PLGA nanoparticles promote immune protection","volume":"111","author":"Tan","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.micpath.2026.108667_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1432989","article-title":"A gram-positive enhancer matrix particles vaccine displaying swine influenza virus hemagglutinin protects mice against lethal H1N1 viral challenge","volume":"15","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2026.108667_bib75","doi-asserted-by":"crossref","first-page":"6219","DOI":"10.1007\/s00253-016-7333-y","article-title":"Therapeutic efficacy of oral immunization with a non-genetically modified lactococcus lactis-based vaccine CUE-GEM induces local immunity against Helicobacter pylori infection","volume":"100","author":"Liu","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2026.108667_bib76","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12426","article-title":"Nongenetically modified -adjuvanted vaccination enhanced innate immunity against","volume":"22","author":"Liu","year":"2017","journal-title":"Helicobacter"},{"key":"10.1016\/j.micpath.2026.108667_bib77","doi-asserted-by":"crossref","first-page":"eadn7786","DOI":"10.1126\/sciadv.adn7786","article-title":"Vaccine targeting to mucosal lymphoid tissues promotes humoral immunity in the gastrointestinal tract","volume":"10","author":"Kocabiyik","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.micpath.2026.108667_bib78","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202404830","article-title":"pH-Responsive \u03b2-Glucans-Complexed mRNA in LNPs as an oral vaccine for enhancing cancer immunotherapy","volume":"36","author":"Luo","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.micpath.2026.108667_bib79","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70274","article-title":"An Engineered Nano-Vesicle Adjuvant Platform (ENAP) for cytokine delivery enables a novel antigen-coordinated vaccine against Helicobacter pylori","volume":"15","author":"Shang","year":"2026","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.micpath.2026.108667_bib80","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/vaccines14050440","article-title":"Bacterial membrane vesicles as versatile platforms for systemic and mucosal vaccines","volume":"14","author":"Park","year":"2026","journal-title":"Vaccines"},{"key":"10.1016\/j.micpath.2026.108667_bib81","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3390\/cells12141826","article-title":"Oral delivery of mRNA vaccine by plant-derived extracellular vesicle carriers","volume":"12","author":"Pomatto","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.micpath.2026.108667_bib82","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3390\/vaccines9101177","article-title":"Buccal and sublingual vaccines: a review on oral mucosal immunization and delivery systems","volume":"9","author":"Trincado","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.micpath.2026.108667_bib83","article-title":"Sublingual dissolving microneedle (SLDMN)-Based vaccine for inducing mucosal immunity against SARS-CoV-2","volume":"12","author":"Kim","year":"2023","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.micpath.2026.108667_bib84","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41577-024-01100-x","article-title":"Viral infection and antiviral immunity in the oral cavity","volume":"25","author":"Hickman","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2026.108667_bib85","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jconrel.2022.10.059","article-title":"Oromucosal delivery of macromolecules: challenges and recent developments to improve bioavailability","volume":"352","author":"Rawas-Qalaji","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.micpath.2026.108667_bib86","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines \u2014 fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2026.108667_bib87","first-page":"421","article-title":"Sensitivity comparison experiment of four testing methods for Helicobacter pylori","volume":"53","author":"Liu","year":"2022","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.micpath.2026.108667_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113740","article-title":"Tough and waterproof microneedles overcome mucosal immunotolerance by modulating antigen release patterns","volume":"382","author":"He","year":"2025","journal-title":"J. Contr. Release"},{"issue":"5","key":"10.1016\/j.micpath.2026.108667_bib89","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3390\/microorganisms11051312","article-title":"Helicobacter pylori and its role in gastric cancer","volume":"11","author":"Reyes","year":"2023","journal-title":"Microorganisms"},{"issue":"7","key":"10.1016\/j.micpath.2026.108667_bib90","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3390\/vaccines13070725","article-title":"Unraveling Helicobacter pylori: insights into pathogenesis, immune evasion, and progress toward effective vaccination","volume":"13","author":"Elbehiry","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.micpath.2026.108667_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2025.101470","article-title":"Decoding the ability of to evade immune recognition and cause disease","volume":"19","author":"Sirit","year":"2025","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.micpath.2026.108667_bib92","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/toxins8060173","article-title":"An overview of Helicobacter pylori VacA toxin biology","volume":"8","author":"Foegeding","year":"2016","journal-title":"Toxins"},{"key":"10.1016\/j.micpath.2026.108667_bib93","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12544","article-title":"VacA, a distinct toxin exerts diverse functionalities in numerous cells: an overview","volume":"24","author":"Chauhan","year":"2019","journal-title":"Helicobacter"},{"key":"10.1016\/j.micpath.2026.108667_bib94","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1080\/1040841X.2025.2575994","article-title":"'s secret resilience: coccoid forms, yeast havens, and outer membrane vesicle release for survival and spread","volume":"51","author":"Ramezani","year":"2025","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2026.108667_bib95","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1016\/j.vaccine.2020.02.036","article-title":"Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against infection","volume":"38","author":"Liu","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2026.108667_bib96","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrmicro3016","article-title":"Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori","volume":"11","author":"Salama","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2026.108667_bib97","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/gidisord7010006","article-title":"The role of the immune response to Helicobacter pylori antigens and its relevance in gastric disorders","volume":"7","author":"Santacroce","year":"2025","journal-title":"Gastrointestinal Disorders"},{"issue":"8","key":"10.1016\/j.micpath.2026.108667_bib98","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3390\/vaccines10081367","article-title":"Current vaccine platforms in enhancing T-Cell response","volume":"10","author":"Ura","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.micpath.2026.108667_bib99","doi-asserted-by":"crossref","DOI":"10.1177\/11779322251331104","article-title":"A reverse vaccinology and immunoinformatic approach for the designing of a novel mRNA vaccine against stomach cancer targeting the potent pathogenic proteins of Helicobacter pylori","volume":"19","author":"Barua","year":"2025","journal-title":"Bioinf. Biol. Insights"},{"key":"10.1016\/j.micpath.2026.108667_bib100","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.micpath.2026.108667_bib101","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jtho.2020.05.005","article-title":"Principles of good clinical trial design","volume":"15","author":"An","year":"2020","journal-title":"J. Thorac. Oncol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026003931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401026003931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:40:44Z","timestamp":1784529644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401026003931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":101,"alternative-id":["S0882401026003931"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108667","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New perspectives in the research of Helicobacter pylori vaccine","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108667","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108667"}}